Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bladder Urothelial Carcinoma, Metastatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00014274
What this trial is testing

Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
European Organisation for Research and Treatment of Cancer - EORTC 238
Testing effectiveness (Phase 2)UnknownNCT03715985
What this trial is testing

Personalized Neo-antigen Vaccine in Advanced Solid Tumors (NeoPepVac)

Who this might be right for
Malignant Melanoma, MetastaticNon Small Cell Lung Cancer MetastaticBladder Urothelial Carcinoma, Metastatic
Herlev Hospital 12
Large-scale testing (Phase 3)Looking for participantsNCT07129993
What this trial is testing

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Who this might be right for
Urothelial CancerBladder Cancer
Daiichi Sankyo 630
Testing effectiveness (Phase 2)Study completedNCT01089088
What this trial is testing

Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium (SUCCINCT)

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Cardiff University 63
Testing effectiveness (Phase 2)Ended earlyNCT02401542
What this trial is testing

Dose Escalation, Expansion Study of Vofatamab (B-701) in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma

Who this might be right for
Locally Advanced or Metastatic Urothelial Cell CarcinomaUrinary Bladder DiseaseUrological Diseases
Rainier Therapeutics 71
Testing effectiveness (Phase 2)Study completedNCT01265940
What this trial is testing

Pazopanib and Vinflunine in Urothelial Cancer of the Bladder

Who this might be right for
Advanced Urothelial Cancer of Bladder After Failure of Platinum-containing Therapy.
Prof. Dr. Thomas Otto 5
Early research (Phase 1)Active Not RecruitingNCT02496208
What this trial is testing

Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors

Who this might be right for
Bladder Small Cell Neuroendocrine CarcinomaBladder Squamous Cell CarcinomaBladder Urothelial Carcinoma+27 more
National Cancer Institute (NCI) 152
Large-scale testing (Phase 3)Looking for participantsNCT07218380
What this trial is testing

Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Who this might be right for
Carcinoma, Transitional CellUrinary Bladder NeoplasmsNeoplasm Metastasis
Eli Lilly and Company 450
Testing effectiveness (Phase 2)Study completedNCT00397488
What this trial is testing

Sunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the Urothelium

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Memorial Sloan Kettering Cancer Center 78
Testing effectiveness (Phase 2)Looking for participantsNCT07667335
What this trial is testing

Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial Cancer

Who this might be right for
Locally Advanced Bladder Urothelial CarcinomaLocally Advanced Renal Pelvis Urothelial CarcinomaLocally Advanced Ureter Urothelial Carcinoma+10 more
Fred Hutchinson Cancer Center 27
Testing effectiveness (Phase 2)Study completedNCT03534804
What this trial is testing

Cabozantinib Plus Pembrolizumab as First-Line Therapy for Cisplatin-Ineligible Advanced Urothelial Carcinoma

Who this might be right for
Metastatic Urothelial CarcinomaBladder Cancer
University of Utah 37
Testing effectiveness (Phase 2)Study completedNCT03219333
What this trial is testing

Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer

Who this might be right for
Carcinoma, Transitional CellUrinary Bladder NeoplasmsUrologic Neoplasms+4 more
Astellas Pharma Inc 219
Not applicableActive Not RecruitingNCT06129084
What this trial is testing

Compare the Results of FGFR Testing by Either ctDNA Blood Testing or Standard Tumor Tissue Testing

Who this might be right for
Metastatic Bladder CancerMetastatic Urothelial Carcinoma
Bernie Eigl 260
Testing effectiveness (Phase 2)Study completedNCT01326871
What this trial is testing

ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer

Who this might be right for
Transitional Cell Carcinoma of BladderUrethra CancerUreter Cancer+1 more
Altor BioScience 68
Early research (Phase 1)Study completedNCT04306900
What this trial is testing

TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers

Who this might be right for
Solid Tumor, Adult
Trishula Therapeutics, Inc. 185
Not applicableUnknownNCT04129606
What this trial is testing

Bladder Perforation Post-TURBT: Definition, Incidence and Natural HistoryStudy

Who this might be right for
Bladder CancerBladder Urothelial CarcinomaTrauma+5 more
Abdelwahab Hashem 300
Early research (Phase 1)Looking for participantsNCT07277413
What this trial is testing

IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Who this might be right for
NSCLC AdenocarcinomaGastroesophageal Cancer (GC)Gastric Adenocarcinoma+10 more
IDEAYA Biosciences 260
Testing effectiveness (Phase 2)Ended earlyNCT03324282
What this trial is testing

First-line Gemcitabine/Cisplatin +/- Avelumab in Locally Advanced or Metastatic Bladder Carcinoma

Who this might be right for
Bladder Carcinoma
University Hospital, Bordeaux 65
Early research (Phase 1)Study completedNCT03236935
What this trial is testing

Phase Ib of L-NMMA and Pembrolizumab

Who this might be right for
Non-Small Cell Lung CancerMalignant MelanomaHead and Neck Squamous Cell Carcinoma+3 more
The Methodist Hospital Research Institute 12
Early research (Phase 1)Study completedNCT04200963
What this trial is testing

A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma

Who this might be right for
Urothelial CarcinomaUrothelial Carcinoma BladderBladder Cancer+18 more
Ikena Oncology 78
Next Page